Estudio inmunohistoquimico de bcl-2 y MIB-1/KI-67 en el carcinoma de mama analisis retrospectivo en 238 casos

Translated title of the contribution: Immunohistochemical detection of bcl-2 and MIB-1/Ki-67 in breast cancer. Retrospective analysis of 238 cases

Alberto S. Sundblad, Chul Ahn, Hector Battifora

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We considered of interest to determine the possible interrelationship between the proliferation-related marker MIB-1/Ki-67 and the bcl-2, a protein involved in the blockage of apoptosis, and whether they contributed to the prognosis of breast cancer. For this purpose we carried out a retrospective immunohistochemical study of 238 cases of stage I and II breast carcinomas with a follow up of at least 5 years. The study revealed that high expression of MIB-1 was associated with high nuclear and histological grades (p < 0,001 for both), negative estrogen receptor status (p = 0.009) and progesterone status (p = 0.004), and younger age (p = 0.014). High bcl-2 expression was associated with smaller tumor size (p = 0.001); positive estrogen and progesterone receptors (p< 0.001 for both); low nuclear grade (p < 0.001), low histological grade (p < 0.002), stage I disease (p = 0.01) and low MIB-1 expression (p = 0.025). The univariate Cox regression showed a significant association of high MIB-1 expression (p = 0.002) and low bcl-2 expression (p = 0.04) with shorter OS. Furthermore, MIB-1 expression was a significant independent predictor of OS (p = 0.002) as showed by stepwise Cox regression analysis.

Original languageSpanish
Pages (from-to)252-258
Number of pages7
JournalMedicina
Volume56
Issue number3
StatePublished - 1996

Fingerprint

Estrogen Receptors
Breast Neoplasms
Progesterone Receptors
Progesterone
Retrospective Studies
Regression Analysis
Apoptosis
Neoplasms
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Estudio inmunohistoquimico de bcl-2 y MIB-1/KI-67 en el carcinoma de mama analisis retrospectivo en 238 casos. / Sundblad, Alberto S.; Ahn, Chul; Battifora, Hector.

In: Medicina, Vol. 56, No. 3, 1996, p. 252-258.

Research output: Contribution to journalArticle

Sundblad, Alberto S. ; Ahn, Chul ; Battifora, Hector. / Estudio inmunohistoquimico de bcl-2 y MIB-1/KI-67 en el carcinoma de mama analisis retrospectivo en 238 casos. In: Medicina. 1996 ; Vol. 56, No. 3. pp. 252-258.
@article{9da1bed482a14d61b8699604973144e6,
title = "Estudio inmunohistoquimico de bcl-2 y MIB-1/KI-67 en el carcinoma de mama analisis retrospectivo en 238 casos",
abstract = "We considered of interest to determine the possible interrelationship between the proliferation-related marker MIB-1/Ki-67 and the bcl-2, a protein involved in the blockage of apoptosis, and whether they contributed to the prognosis of breast cancer. For this purpose we carried out a retrospective immunohistochemical study of 238 cases of stage I and II breast carcinomas with a follow up of at least 5 years. The study revealed that high expression of MIB-1 was associated with high nuclear and histological grades (p < 0,001 for both), negative estrogen receptor status (p = 0.009) and progesterone status (p = 0.004), and younger age (p = 0.014). High bcl-2 expression was associated with smaller tumor size (p = 0.001); positive estrogen and progesterone receptors (p< 0.001 for both); low nuclear grade (p < 0.001), low histological grade (p < 0.002), stage I disease (p = 0.01) and low MIB-1 expression (p = 0.025). The univariate Cox regression showed a significant association of high MIB-1 expression (p = 0.002) and low bcl-2 expression (p = 0.04) with shorter OS. Furthermore, MIB-1 expression was a significant independent predictor of OS (p = 0.002) as showed by stepwise Cox regression analysis.",
author = "Sundblad, {Alberto S.} and Chul Ahn and Hector Battifora",
year = "1996",
language = "Spanish",
volume = "56",
pages = "252--258",
journal = "Medicina",
issn = "0025-7680",
publisher = "Instituto de Investigaciones Medicas",
number = "3",

}

TY - JOUR

T1 - Estudio inmunohistoquimico de bcl-2 y MIB-1/KI-67 en el carcinoma de mama analisis retrospectivo en 238 casos

AU - Sundblad, Alberto S.

AU - Ahn, Chul

AU - Battifora, Hector

PY - 1996

Y1 - 1996

N2 - We considered of interest to determine the possible interrelationship between the proliferation-related marker MIB-1/Ki-67 and the bcl-2, a protein involved in the blockage of apoptosis, and whether they contributed to the prognosis of breast cancer. For this purpose we carried out a retrospective immunohistochemical study of 238 cases of stage I and II breast carcinomas with a follow up of at least 5 years. The study revealed that high expression of MIB-1 was associated with high nuclear and histological grades (p < 0,001 for both), negative estrogen receptor status (p = 0.009) and progesterone status (p = 0.004), and younger age (p = 0.014). High bcl-2 expression was associated with smaller tumor size (p = 0.001); positive estrogen and progesterone receptors (p< 0.001 for both); low nuclear grade (p < 0.001), low histological grade (p < 0.002), stage I disease (p = 0.01) and low MIB-1 expression (p = 0.025). The univariate Cox regression showed a significant association of high MIB-1 expression (p = 0.002) and low bcl-2 expression (p = 0.04) with shorter OS. Furthermore, MIB-1 expression was a significant independent predictor of OS (p = 0.002) as showed by stepwise Cox regression analysis.

AB - We considered of interest to determine the possible interrelationship between the proliferation-related marker MIB-1/Ki-67 and the bcl-2, a protein involved in the blockage of apoptosis, and whether they contributed to the prognosis of breast cancer. For this purpose we carried out a retrospective immunohistochemical study of 238 cases of stage I and II breast carcinomas with a follow up of at least 5 years. The study revealed that high expression of MIB-1 was associated with high nuclear and histological grades (p < 0,001 for both), negative estrogen receptor status (p = 0.009) and progesterone status (p = 0.004), and younger age (p = 0.014). High bcl-2 expression was associated with smaller tumor size (p = 0.001); positive estrogen and progesterone receptors (p< 0.001 for both); low nuclear grade (p < 0.001), low histological grade (p < 0.002), stage I disease (p = 0.01) and low MIB-1 expression (p = 0.025). The univariate Cox regression showed a significant association of high MIB-1 expression (p = 0.002) and low bcl-2 expression (p = 0.04) with shorter OS. Furthermore, MIB-1 expression was a significant independent predictor of OS (p = 0.002) as showed by stepwise Cox regression analysis.

UR - http://www.scopus.com/inward/record.url?scp=0030332451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030332451&partnerID=8YFLogxK

M3 - Article

VL - 56

SP - 252

EP - 258

JO - Medicina

JF - Medicina

SN - 0025-7680

IS - 3

ER -